Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

(2017) Michael Weller et al.   LANCET ONCOLOGY

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

(2017) Jonathan Strosberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome

(2017) Aida Kiviniemi et al.   Oncotarget

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort

(2016) Emeline Tabouret et al.   ACTA NEUROPATHOLOGICA

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co-deleted anaplastic gliomas

(2016) Franck Bielle et al.   BRAIN PATHOLOGY

Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours

(2016) Eleonora Vitali et al.   ENDOCRINE-RELATED CANCER

GlioVis data portal for visualization and analysis of brain tumor expression datasets

(2016) Robert L. Bowman et al.   NEURO-ONCOLOGY

Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors

(2016) Ki Byung Song et al.   PANCREAS

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Somatostatin receptor expression in hepatocellular carcinoma: prognostic and therapeutic considerations

(2014) Omar Abdel-Rahman et al.   ENDOCRINE-RELATED CANCER

Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations

(2014) D. Figarella-Branger et al.   NEURO-ONCOLOGY

Clinicopathologic characteristics of pancreatic neuroendocrine tumors and relation of somatostatin receptor type 2A to outcomes

(2013) Kosuke Okuwaki et al.   CANCER

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

(2013) John J. Zaknun et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Somatostatin receptors: From signaling to clinical practice

(2013) Marily Theodoropoulou et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide

(2013) Olivera Casar-Borota et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Illuminating somatostatin analog action at neuroendocrine tumor receptors

(2013) Jean Claude Reubi et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment

(2013) YAO LIU et al.   Oncology Letters

Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility

(2012) M. Annunziata et al.   HUMAN REPRODUCTION

The role of somatostatin and dopamine D2 receptors in endocrine tumors

(2011) Federico Gatto et al.   ENDOCRINE-RELATED CANCER

Radiopeptide Imaging and Therapy in Europe

(2011) V. Ambrosini et al.   JOURNAL OF NUCLEAR MEDICINE

Clinical Significance of Protein Expression of Cyclooxygenase-2 and Somatostatin Receptors in Gastroenteropancreatic Neuroendocrine Tumors

(2011) Hee Sung Kim et al.   Cancer Research and Treatment

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

Response of Recurrent High-Grade Glioma to Treatment with 90Y-DOTATOC

(2010) D. Heute et al.   JOURNAL OF NUCLEAR MEDICINE

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function

(2008) J. D. Cahoy et al.   JOURNAL OF NEUROSCIENCE

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

(2008) Francois Ducray et al.   Molecular Cancer

Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors

(2007) Tullio Florio   Frontiers in Bioscience-Landmark